Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P000006/S076

Titan Inflatable Penile Prosthesis

Coloplast Corp. · Decision date Aug 13, 2026

FDA DECISIONP000006/S076

What did the FDA decide?

FDA records P000006/S076 as a supplement to PMA P000006, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Aug 13, 2026.

FDA approval order statement

implements a non-destructive in-process test method for measuring Bioflex coating thickness on kink resistant tubing
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Gastroenterology, Urology
Decision date
Aug 13, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P000006/S076
Regulatory pathway
PMA supplement
Product code
FHW
Decision code
OK30
Decision date
Aug 13, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Device, impotence, mechanical/hydraulic.

Product code
FHW
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P000006/S071 · Related supplement

    Titan Inflatable Penile Prosthesis

  2. P000006/S072 · Related supplement

    Titan Inflatable Penile Prosthesis (IPP)

  3. P000006/S075 · Related supplement

    Titan Inflatable Penile Prosthesis

  4. P000006/S074 · Related supplement

    Titan Inflatable Penile Prosthesis

  5. P000006/S076 received

    Application receipt date recorded by FDA.

  6. P000006/S076 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P000006. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P000006

Product / regulatory recordCompanyPathwayDecision dateSource
Coloplast Corp.PMA supplementAug 14, 2025FDA
Coloplast Corp.PMA supplementJun 2, 2026FDA
Coloplast Corp.PMA supplementJul 20, 2026FDA
Coloplast Corp.PMA supplementJul 21, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Coloplast Corp.

Headquarters
Not reported
Brand website
coloplast.com
FDA applicant address
1601 W. River Rd. N., Plymouth, MN, 55411

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records